A new antibiotic, maridomycin (MDM), which is mainly active against gram-positive bacteria was isolated from a culture filtrate of Streptomyces hygroscopicus (6, 7) . This basic macrolide antibiotic consists of six components; their chemical structures differ only in the acyl groups at positions 3 and 4" (Fig. 1) , and they have similar chemical properties (5, 6) .
The protecting effects of orally administered MDM and some commercially available macrolides against experimental staphylococcal, streptococcal, and diplococcal infections in mice were compared ( Table 1) . The minimum inhibitory concentration of each component of MDM against Staphylococcus aureus, Streptococcus pyogenes, and Diplococcus pneumoniae as well as data about the protecting action of orally administered MDM components against S. aureus infections are shown in Table 2 .
To improve the biological properties, chemical modification of MDM was performed. Certain functional groups in MDM complex, such as the secondary hydroxyls at positions 9 and 2', the double bond at position 10, and the epoxide at position 12, lend themselves to chemical modifications, and some derivatives of MDM were prepared with a view to improving biological properties as compared with the parent antibiotic. Such parameters as the (i) antibacterial activity in vitro (Table 4 ), (ii) blood level attained in rats after oral administration, (iii) therapeutic effect against staphylococcal infection by oral administration, (iv) acute toxicity in mice, and (v) subacute toxicity in rats were determined, and the results with the derivatives were compared with those obtained with MDM.
MATERIALS AND METHODS Preparation of derivatives. Either the MDM (complex) containing predominantly MDM III or an individual component of the MDM complex was used for preparation of the derivatives. Individual MDMs were obtained by partition or adsorption chromatography of the MDM complex (6).
9-Monoacyl MDM analogs. To a solution of the MDM complex or a component of MDM (0.1 mol) in pyridine (300 ml), an acid chloride (0.12 mol) was added dropwise under ice-cooling, and the reaction mixture was stirred at 0 to 5 C for 1 to 2.5 h and poured into 4 liters of ice water. The reaction mixture was extracted twice with AcOEt (2 liters), and the extract was washed with 2% NaHCOs followed by H,O, dehydrated with Na2SO4, and concentrated in vacuo. The concentrated residue was purified by precipitation from Me2CO-petroleum ether.
2'-Monoacyl MDM analogs. A solution of MDM complex or a component of MDM (0.1 mol) and acid anhydride (0.3 to 0.6 mol) in Me2CO (500 ml) was allowed to stand at 0 to 5 C for 15 h. The reaction mixture was added into 3% NaHCO,-ice water and extracted three times with AcOEt. After washing, dehydration, and concentration of the extract, the residue was purified by precipitation from AcOEt-or Me2CO-hexane.
9,2'-Diacyl MDM analogs. A solution of MDM complex, a component of MDM, or one of their monoacylates and excess of acid anhydride in pyridine was held at room temperature ovemight, and then was added into ice water. The precipitate was filtered and washed with H2O. The mother liquor was The antimicrobial activity of these samples was determined by the cup method by using S. lutea as the test organism. The diluent for the standard solution (20 to 1.25 gg/ml) of each antibiotic was normal rat plasma.
Therapeutic effect in mice. Female CF-1/H mice weighing 18 to 22 g were infected intraperitoneally with 0.5 ml of a 5% mucin suspension containing 0.1 its volume of an overnight culture of S. aureus 308A-1 in brain-heart-infusion broth. Treatment was performed by a single oral administration of the antibiotic immediately after infection.
The 50% (median) effective dose (ED50) was calculated from the survival rate of the animals on the 7th day by the method of Reed and Muench (9) .
Acute toxicity in mice. Male ICR-JCL mice weighing 18 to 24 g were used. Various doses of the antibiotic suspended in 5% gum arabic were administered orally or intraperitoneally to mice in groups of three, and the 50% (median) lethal dose (LD,0) was calculated on the basis of mortality 7 days after administration by the method of Litchfield and Wilcoxon (4) .
Stability in the acidic aqueous solution. The antibiotic was dissolved in MeOH at the concentration of 10 mg/ml. A solution of 1 mg/ml diluted with VOL. 4, 1973 on October 28, 2017 by guest http://aac.asm.org/ Sorensen citrate buffer (pH 4.0) or simulated gastric juice (pH 1.3) was incubated at 37 C for 2 h. At appropriate intervals, the sample was immediately diluted with Sorensen phosphate buffer (pH 8.0), and the antimicrobial activity was estimated by the cup method by using S. lutea as the test organism. The individual compound was used as a standard.
Preliminary subacute toxicity in rats. A group of five male Sprague-Dawley rats (SD-JCL) weighing 88 to 112 g each (average 100 g) were used. The animals were maintained on the CE-2 diet and supplied water ad libitum. The antibiotic, suspended in 3% hydrogenated cocoanut oil, was administered orally 10 times for 13 days, and the body weights of animals were measured before dosing. hydroxide and benzene, and that (iii) acid anhydride in pyridine is preferable for 9, 2'-diacylates via the 2'-acylates. The structures of these derivatives were ascertained by the following findings. As anticipated, the infrared spectrum of 9,2'-diacetyl MDM showed enhanced absorptions at 1,730 and 1,250 cm-' (CHCl,), whereas only residual absorption at 3,470 cm-in the hydroxyl region was observed. In the nuclear magnetic resonance (NMR) spectrum, new signals were observed at 2.00 ppm (2 x 3 H, s, -OAc), and signals at 3.52 ppm (1H, q, J = 7, 11 Hz, H2) and 4 .00 ppm (1H, m, H,) of MDM shifed to 4.9 to 5.0 ppm. It was concluded, therefore, that two acetyl groups had been introduced into positions 9 and 2', and that the hydroxyl group at position 3" was still free.
RESULTS AND DISCUSSION
The structures of 9-acyl MDM were determined from a low-field shift of proton at position 9, and no shift of proton at position 2' and 1' (4.46 ppm, 1H, d, J = 7 Hz) in the NMR spectrum.
Similarly the low-field shift of proton at position 2' and 1', high-field shift of protons of the dimethylamino group, and no shift of proton at position 9 in the NMR spectrum was evi- dence for 2'-acylation. Furthermore, the results of the NMR spin-decoupling confirmed the structure of the derivatives (Fig. 2) . MDM itself, and its tested derivatives, showed better acid stability than did propionylerythromycin lauryl sulfate (erythromycin estolate) (10) .
Biological activities. The minimum inhibitory concentration of 9-acyl and 2'-acyl MDM are shown in Table 4 . The in vitro antibacterial activities of lower aliphatic fatty acid esters against S. aureus and B. subtilis were almost equal to those of MDM. A decrease in activity was observed with acyl groups of longer carbon chain at position 9 or 2'. When the antibacterial activities were determined by diffusion methods, however, all of the acyl derivatives showed relatively fewer activities with an increase of carbon chain length among the ester groups. Antibacterial activities of the diacyl derivatives and acyl derivatives of TH-MDM showed the same tendency as those of the monoacyl derivatives. The hydrogenation of the double bond and the epoxide in MDM did not influence the activity in any significant manner.
The blood levels obtained with MDM derivatives were compared with those produced by MDM. As shown in Fig. 3 , the blood levels of 9-acetyl, 9-propionyl, and 9-butyryl MDM were about two to three times higher than those of MDM. A longer duration of the blood levels was also observed. Among the 9-acyl MDMs, the 9-propionyl ester was found to be the best.
On the other hand, the 2'-acyl derivatives showed almost the same blood levels as MDM, contrary to the observations reported on the blood level of 2'-propionylerythromycin (1). The 9, 2'-diacyl derivatives also brought about higher and more prolonged blood levels than did MDM. TH-MDM showed almost the same blood level as MDM, whereas its triacetate gave high blood levels for a much longer time. A comparison of blood levels attained in rats with MDM and its derivatives with those attained with some known macrolides showed that erythromycin estolate and kitasamycin (3) gave values comparable to those with MDM. Similarly, the blood level of josamycin (8) was almost equal in value to that of 9,2'-diacetyl MDM, but was lower than that of 9-propionyl MDM. The data presented above would help in deciding whether the derivatives which are well absorbed from the alimentary tract might prove effective against infections.
The protecting effect of MDM derivatives was compared with that of MDM (Fig. 4) .
Significantly better therapeutic effect was observed with 9-acetyl, 9-propionyl, 9-butyryl, 9-isobutyryl, 9-crotonyl, 9, 2'-diacetyl, 9-propionyl-2'-acetyl, 9,2'-dipropionyl MDM, and triacetyl TH-MDM. 2'-Acyl derivatives were less active than MDM. As is to be expected, the derivatives which had less antibacterial activity in vitro or attained low blood levels also showed relatively less therapeutic effect in vivo. 9-Propionyl MDM showed good therapeutic effect as compared with erythromycin estolate or josamycin.
The introduction of an ester group into position 9 favorably influences the protective effect and blood level compared with that resulting from introduction into position 2'. From the viewpoint of structure-activity relationships, the total number of carbon atoms in the ester groupings at position 3, 9, and 4" was more important than was the number of carbon atoms in the individual ester grouping. It was thus tentatively assumed that compounds possessing a total of 9 carbon atoms were significantly active.
When MDM derivatives were administered
